Advertisement
Advertisement

IPHA

IPHA logo

Innate Pharma S.A. ADS

1.96
USD
+0.02
+0.82%
Apr 17, 15:58 UTC -4
Closed
exchange

After-Market

1.97

+0.01
+0.72%

Innate Pharma S.A. ADS Profile

About

Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.

Info & Links

CEO

Headquarters

--

Sector

Medical

Website

--

Auditor

Share holders

--

Employees

--

Innate Pharma S.A. ADS Statistics

Valuation Measures

Market Capitalization2

165.11M

Enterprise Value

126.80M

Enterprise Value/EBITDA(ttm)

--

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

--

Price to Book(mrq)

5.90

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

0.00%

Operating Margin(ttm)

--

Profit Margin(ttm)

0.00%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

0.00%

Return on Assets(ttm)

--

Income Statement

Revenue(ttm)

0.00

Revenue Per Share(ttm)

--

Gross Profit(ttm)

0.00

EBITDA(ttm)3

0.00

Net Income Available to Common(ttm)

0.00

Diluted EPS(ttm)

--

Share Statistics

Beta (5Y Monthly)

0.27

52-Week Change

-16.77%

S&P 500 52-Week Change

5.43%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

--

Dividend Yield

0.00%

Float4

57.10M

% Held by Insiders

31.89%

% Held by Institutions

0.16%

Balance Sheet

Total Cash(mrq)

87.40M

Total Cash Per Share(mrq)

--

Total Debt(mrq)

33.54M

Total Debt/Equity(mrq)

0.00%

Current Ratio(mrq)

--

Quick Ratio(mrq)

--

Book Value Per Share(mrq)

--

Cash Flow

Operating Cash Flow Per Share(ytd)

--

Free Cash Flow(ytd)

0.00

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement